Highlights from Ayrton Drug’s Annual Report- Chairman’s Letter

The Chairman said 2012 was a tough year for the company. Top-line (Sales) grew by 14.68% but the bottom-line ( Profit after tax) fell by 13.61%. This he attributed to the depreciating cedi and astronomical increases in interest rates, among other factors.Earnings per share fell from 0.0133p in 2011 to 0.0115 in 2012 whiles dividend … Continue reading Highlights from Ayrton Drug’s Annual Report- Chairman’s Letter

Advertisements

Earnings Season on the Ghana Stock Exchange: Half Year Reports

We are in the first half Earnings Season on the Ghana Stock Exchange and in my earlier post about Benso Oil Palm Plantation (BOPP), i.e. Half Year Performance of BOPP, I looked at how BOPP performed on the exchange and for the first half. Below are the various performances for some of the companies listed … Continue reading Earnings Season on the Ghana Stock Exchange: Half Year Reports